The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Whilst we're on the "read it" vibe...
The previous RNS stated "To date, neither Avacta nor Mologic have received any update from the MHRA." Which seemingly means that their "independent regulatory consulting agency" could have received an update and they in turn may have updated A & M, but since the NHRA didn't update A or M directly, the wording on the RNS was correct.
Davand: try "Yeah sorry about the strain thing, I was wrong about that." instead we get "LFTs aren't accurate enough." A sudden change of tack. It rather just sounds like you're trying to downplay LFTs in general. Is that what is the current topic in the basher handbook?
What he said.
Although I'll add, what you're saying suggests that travel would be allowed for some variants but not others?
Who cares which variant you have, you're not getting on board.
Our general consensus, based on prior applications, is that the MHRA take about twelve days to process an application.
Ophidian has added twelve to a week last Monday and magically predicted that it'll be today. Wow. He is some kind of mystic.
Or maybe tomorrow.
How long does natural immunity (exposure leads to antibodies) last?
How long does the vaccine's effect last?
Are we going to be having booster jabs every three months?
Will we ever reach herd immunity in the UK, never mind the world.
Does the vaccine prevent infection, or are people who have had the vaccine going to be the new pool of people bouncing the virus around until a truly escape mutation arises?
If the UK are turning their back on the expenditure of mass testing. Will there be anyone else interested in a test with phenomenal s/s with the added convenience of AN?